FGFR3 and esophageal cancer: In addition to brain tumors, to date, the FGFR3-TACC3 fusion protein has been reported in several solid tumors [30], including non-small cell lung cancer [31], cervical cancer [32], esophageal cancer [33], gastric cancer [34], and SCCHN [35].